Disclosure Of Entity's Operating Segments [Text Block]

Heidelberg Pharma AG - Filing #6821989

Concept 2020-12-01 to
2021-11-30
2020-12-01 to
2021-11-30
As at
2021-11-30
2019-12-01 to
2020-11-30
2019-12-01 to
2020-11-30
As at
2020-11-30
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
1.749.829 EUR
8.487.938 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
13 EUR
71 EUR
Tax expense (income)
0 EUR
0 EUR
Profit (loss) before tax
26.138.702 EUR
18.369.038 EUR
Profit (loss)
26.138.702 EUR
26.138.702 EUR
18.369.038 EUR
18.369.038 EUR
Assets
21.732.119 EUR
19.608.792 EUR
Investments accounted for using equity method
0 EUR
0 EUR
Cash flows from (used in) operating activities
26.612.520 EUR
17.892.611 EUR
Cash flows from (used in) investing activities
1.401.953 EUR
1.289.794 EUR
Cash flows from (used in) financing activities
29.169.662 EUR
14.290.458 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.